PubMed:23537957 / 153-430 JSONTXT

{"project":"PubMed_ArguminSci","denotations":[{"id":"T1","span":{"begin":0,"end":277},"obj":"DRI_Approach"}],"text":"The genomic sequences of low and high passages of the United States infectious laryngotracheitis (ILT) vaccine strains CEO and TCO were determined using hybrid next generation sequencing in order to define genomic changes associated with attenuation and reversion to virulence."}

{"project":"Goldhamster2_Cellosaurus","denotations":[{"id":"T2","span":{"begin":98,"end":101},"obj":"CVCL_F909|Transformed_cell_line|Homo sapiens"},{"id":"T3","span":{"begin":127,"end":130},"obj":"CVCL_HE32|Cancer_cell_line|Homo sapiens"},{"id":"T4","span":{"begin":214,"end":221},"obj":"CVCL_0238|Cancer_cell_line|Homo sapiens"}],"text":"The genomic sequences of low and high passages of the United States infectious laryngotracheitis (ILT) vaccine strains CEO and TCO were determined using hybrid next generation sequencing in order to define genomic changes associated with attenuation and reversion to virulence."}

{"project":"GoldHamster","denotations":[{"id":"T13","span":{"begin":111,"end":118},"obj":"D013180"},{"id":"T14","span":{"begin":111,"end":118},"obj":"D013180"},{"id":"T15","span":{"begin":119,"end":122},"obj":"PR:A5HZ59"},{"id":"T17","span":{"begin":127,"end":130},"obj":"CVCL_HE32"},{"id":"T16","span":{"begin":127,"end":130},"obj":"CHEBI:73156"},{"id":"T18","span":{"begin":127,"end":130},"obj":"C537842"},{"id":"T19","span":{"begin":153,"end":159},"obj":"37965"},{"id":"T20","span":{"begin":153,"end":159},"obj":"D002678"},{"id":"T21","span":{"begin":267,"end":276},"obj":"GO:0009405"},{"id":"T22","span":{"begin":267,"end":276},"obj":"GO:0009406"},{"id":"T23","span":{"begin":267,"end":276},"obj":"GO:0016032"}],"text":"The genomic sequences of low and high passages of the United States infectious laryngotracheitis (ILT) vaccine strains CEO and TCO were determined using hybrid next generation sequencing in order to define genomic changes associated with attenuation and reversion to virulence."}

{"project":"Allie","denotations":[{"id":"SS1_23537957_1_0","span":{"begin":68,"end":96},"obj":"expanded"},{"id":"SS2_23537957_1_0","span":{"begin":98,"end":101},"obj":"abbr"}],"relations":[{"id":"AE1_23537957_1_0","pred":"abbreviatedTo","subj":"SS1_23537957_1_0","obj":"SS2_23537957_1_0"}],"text":"The genomic sequences of low and high passages of the United States infectious laryngotracheitis (ILT) vaccine strains CEO and TCO were determined using hybrid next generation sequencing in order to define genomic changes associated with attenuation and reversion to virulence."}